Jia Jie Biomedical Co., Ltd.

TPEX:4109 Stock Report

Market Cap: NT$2.4b

Jia Jie Biomedical Past Earnings Performance

Past criteria checks 2/6

Jia Jie Biomedical has been growing earnings at an average annual rate of 18.5%, while the Personal Products industry saw earnings growing at 18.5% annually. Revenues have been declining at an average rate of 3.7% per year. Jia Jie Biomedical's return on equity is 13.7%, and it has net margins of 43.3%.

Key information

18.5%

Earnings growth rate

16.7%

EPS growth rate

Personal Products Industry Growth13.9%
Revenue growth rate-3.7%
Return on equity13.7%
Net Margin43.3%
Last Earnings Update31 Dec 2023

Recent past performance updates

Recent updates

How Much Did Jia Jie Biomedical's(GTSM:4109) Shareholders Earn From Share Price Movements Over The Last Five Years?

Jan 21
How Much Did Jia Jie Biomedical's(GTSM:4109) Shareholders Earn From Share Price Movements Over The Last Five Years?

Revenue & Expenses Breakdown
Beta

How Jia Jie Biomedical makes and spends money. Based on latest reported earnings, on an LTM basis.


Earnings and Revenue History

TPEX:4109 Revenue, expenses and earnings (TWD Millions)
DateRevenueEarningsG+A ExpensesR&D Expenses
31 Dec 233331441759
30 Sep 23335-211659
30 Jun 23338-381629
31 Mar 23320-261469
31 Dec 22318-51219
30 Sep 2231271098
30 Jun 222835998
31 Mar 222656905
31 Dec 212425814
30 Sep 21238-13842
30 Jun 21237-8861
31 Mar 21250-32870
31 Dec 20270-32900
30 Sep 20279-36920
30 Jun 20294-43951
31 Mar 20327-171011
31 Dec 19343-241072
30 Sep 19356301162
30 Jun 19384321242
31 Mar 1939431382
31 Dec 1840221502
30 Sep 18446-2451722
30 Jun 18459-2631903
31 Mar 18476-2461883
31 Dec 17522-2321883
30 Sep 17523-201743
30 Jun 17529-61654
31 Mar 1757751668
31 Dec 166261217412
30 Sep 167282116918
30 Jun 168023416725
31 Mar 167953716928
31 Dec 157973816931
30 Sep 157122917029
30 Jun 156812917127
31 Mar 156462716724
31 Dec 145892016321
30 Sep 146163117424
30 Jun 146033217519
31 Mar 145952518316
31 Dec 135982218012
30 Sep 13622211728
30 Jun 13622201668

Quality Earnings: 4109 has a large one-off gain of NT$200.1M impacting its last 12 months of financial results to 31st December, 2023.

Growing Profit Margin: 4109 became profitable in the past.


Free Cash Flow vs Earnings Analysis


Past Earnings Growth Analysis

Earnings Trend: 4109 has become profitable over the past 5 years, growing earnings by 18.5% per year.

Accelerating Growth: 4109 has become profitable in the last year, making the earnings growth rate difficult to compare to its 5-year average.

Earnings vs Industry: 4109 has become profitable in the last year, making it difficult to compare its past year earnings growth to the Personal Products industry (25.3%).


Return on Equity

High ROE: 4109's Return on Equity (13.7%) is considered low.


Return on Assets


Return on Capital Employed


Discover strong past performing companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.